Ireland — National Centre for Pharmacoeconomics
Tracked across 1 events · 23 articles · First seen Aug 14, 2026 · Last active Aug 25, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Regulatory
Impact: The NCPE's cost-effectiveness assessment informed the HSE Drugs Group's initial negative recommendation, citing high cost and evidence uncertainties. Its analysis was central to the debate, though the final decision overrode its recommendation.
Aug 14, 2026 · 23 articles
ERGEN INTELLIGENCE
Track Ireland — National Centre for Pharmacoeconomics live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard